Ypsomed develops, manufactures and sells injection and infusion systems for pharmaceutical and biotechnology companies. The Company operates through Ypsomed Diabetes Care, Ypsomed Delivery Systems, and Others segments. The Ypsomed Delivery Systems segment offers various injection systems, such as pen injectors, auto injectors and dual-chamber pens, as well as insulin pens, other diabetes pens, pens for growth hormones and other pens. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories and other day-to-day items for diabetics. The Others segment offers precision turned parts.
Market capitalization (20-Sept-2021)
Closing stock price (20-Sept-2021)
Ypsomed has 1.28k Twitter Followers. The number of followers has increased 0.5% month over month and increased 1% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Ypsomed founded?
Ypsomed was founded in 2003.
Who are Ypsomed key executives?
Ypsomed's key executives are Simon Michel, Willy Michel and Niklaus Ramseier.
How many employees does Ypsomed have?
Ypsomed has 1,737 employees.
Who are Ypsomed competitors?
Competitors of Ypsomed include GlucoRx, Metavention and GI Windows.
Where is Ypsomed headquarters?
Ypsomed headquarters is located at Brunnmattstrasse 6, Burgdorf.
Where are Ypsomed offices?
Ypsomed has offices in Burgdorf, Solothurn, Mona Vale, Wien and in 15 other locations.
How many offices does Ypsomed have?
Ypsomed has 21 offices.
Receive alerts for 300+ data fields across thousands of companies